| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.7 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.02 | 0.7 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.018 | 0.7 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.016 | 0.7 |